Bavarian Nordic A/S (OTCMKTS:BVNRY) Sees Large Decrease in Short Interest

Bavarian Nordic A/S (OTCMKTS:BVNRYGet Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 500 shares, a decline of 54.5% from the April 30th total of 1,100 shares. Based on an average trading volume of 600 shares, the short-interest ratio is presently 0.8 days.

Shares of Bavarian Nordic A/S stock opened at $10.07 on Friday. The company has a fifty day moving average of $7.89 and a 200 day moving average of $10.69. Bavarian Nordic A/S has a fifty-two week low of $5.85 and a fifty-two week high of $19.25.

Bavarian Nordic A/S (OTCMKTS:BVNRYGet Rating) last issued its earnings results on Friday, March 4th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The company had revenue of $83.65 million for the quarter, compared to the consensus estimate of $93.33 million. On average, sell-side analysts forecast that Bavarian Nordic A/S will post -1.07 EPS for the current year.

A number of equities research analysts have recently issued reports on BVNRY shares. Cowen downgraded shares of Bavarian Nordic A/S from an “outperform” rating to a “market perform” rating in a research report on Friday, February 4th. Zacks Investment Research raised shares of Bavarian Nordic A/S from a “sell” rating to a “hold” rating in a report on Tuesday.

About Bavarian Nordic A/S (Get Rating)

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.

Read More

Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with's FREE daily email newsletter.